Class action lawsuits have been filed against Lakeland Industries (LAKE) and Navan Inc. (NAVN) for allegedly making materially false and misleading statements to investors. Lakeland is accused of failing to disclose operational issues with its Pacific Helmets and Jolly businesses, tariff headwinds, and deteriorating financial results. Navan is accused of failing to disclose increased sales and marketing expenses (39% increase) needed to sustain growth at the time of its IPO. Both cases have lead plaintiff deadlines of April 24, 2026.

Navan, Inc. faces a securities class action lawsuit alleging failure to disclose material information regarding increased sales and marketing expenses. Investors who purchased shares in the October 2025 IPO have until April 24, 2026 to file lead plaintiff applications. The lawsuit claims the company's stock fell sharply when true details about the 39% increase in quarterly marketing expenses became public.

Kahn Swick & Foti, LLC announces a class action securities lawsuit against Navan, Inc. for allegedly failing to disclose material information in its October 2025 IPO offering documents. The lawsuit claims the company concealed a 39% increase in sales and marketing expenses to nearly $95 million in Q3 2025. Investors who purchased shares during the IPO and suffered losses have until April 24, 2026 to request lead plaintiff status.

Shareholder class action lawsuits have been filed against Zynex, Inc., Lakeland Industries, Inc., and Navan, Inc. The Zynex lawsuit alleges the company shipped products in excess of need, inflated revenue, filed false insurance claims, and engaged in illegal overbilling. Investors who purchased shares during specified periods and experienced significant losses are encouraged to contact the law firm.

Navan, Inc. (Nasdaq: NAVN) faces a securities fraud lawsuit alleging that its October 2025 IPO offering materials failed to disclose increased sales and marketing spending and slowing revenue trends. The stock declined from $25 at IPO to $12.90 following a December 2025 disclosure of higher expenses and CFO departure. Investors who purchased shares may be eligible to recover losses, with a lead plaintiff deadline of April 24, 2026.

A class action lawsuit has been filed against Navan, Inc. (NASDAQ: NAVN) alleging that its IPO offering documents were false and misleading regarding increased sales and marketing expenses. The company's stock has declined over 60% from its $25 IPO price to $9.01 per share. Investors who purchased Navan securities have until April 24, 2026 to apply as lead plaintiff.

A securities class action lawsuit has been filed against Navan, Inc. alleging that its October 2025 IPO offering documents were materially false and misleading. The company allegedly failed to disclose plans to increase sales and marketing expenses by 39% shortly after the IPO. Following the December 2025 earnings announcement revealing this expense increase, Navan's stock price fell approximately 12% and has since declined nearly 63% from its $25 IPO price to $9.20 per share.

a16z Capital Management disclosed a $465 million investment in Navan, acquiring approximately 27.2 million shares in Q4 2025. The investment makes Navan the fund's second-largest holding at 29.4% of its 13F reportable assets. Navan has evolved from a corporate travel booking platform into an integrated enterprise spending and payments solution leveraging AI for travel, expense, and payment management.

Pomerantz LLP is investigating potential securities fraud claims on behalf of investors in Beta Bionics, CVRx, and Navan. Beta Bionics experienced a significant stock price decline of 37% following the announcement of slower-than-expected patient growth in Q4 2025, with new patient starts increasing 36% year-over-year compared to 68% in the prior quarter.

Robbins Geller Rudman & Dowd LLP has launched an investigation into Navan, Inc. for potential violations of U.S. federal securities laws. The investigation follows Navan's December 2025 earnings report, which revealed a significant GAAP net loss of $225 million (compared to $42 million in Q3 2024), a decline in usage yield, and the departure of its CFO. The stock fell nearly 12% to $12.90, well below its October 2025 IPO price of $25.00.

Law firm Kirby McInerney LLP is investigating Navan, Inc. following its October 2025 IPO at $25/share. The company reported significant financial deterioration in Q3 2026 with a $79 million GAAP operating loss (vs. $19 million prior year) and a -41% operating margin. The CFO departed six weeks post-IPO with accelerated vesting and $3.7 million severance, triggering an 11.9% stock price decline to $12.90.

Law firm Bragar Eagel & Squire is investigating Navan Inc. for potential securities law violations following the company's disappointing third quarter fiscal 2026 results, which revealed a $79 million GAAP operating loss compared to $19 million the prior year, and a 41% operating margin decline. The investigation was triggered after the company's CFO departed just six weeks post-IPO, receiving accelerated vesting and a $3.7 million severance package. Navan's stock fell 11.9% to $12.90 per share on December 16, 2025, following the announcement.